Nicholas Riley - Search Results

Year	Number of Results
2010	2
2011	1
2014	4
2015	8
2016	8
2017	9
2018	12
2019	10
2020	21
2021	16
2022	6

1

Lysosome-targeting chimaeras for degradation of extracellular proteins.

Banik SM, Pedram K, Wisnovsky S, Ahn G, Riley NM, Bertozzi CR. Banik SM, et al. Among authors: riley nm. Nature. 2020 Aug;584(7820):291-297. doi: 10.1038/s41586-020-2545-9. Epub 2020 Jul 29. Nature. 2020. PMID: 32728216 Free PMC article.

2

Cell type-selective secretome profiling in vivo.

Wei W, Riley NM, Yang AC, Kim JT, Terrell SM, Li VL, Garcia-Contreras M, Bertozzi CR, Long JZ. Wei W, et al. Among authors: riley nm. Nat Chem Biol. 2021 Mar;17(3):326-334. doi: 10.1038/s41589-020-00698-y. Epub 2020 Nov 16. Nat Chem Biol. 2021. PMID: 33199915 Free PMC article.

3

LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation.

Ahn G, Banik SM, Miller CL, Riley NM, Cochran JR, Bertozzi CR. Ahn G, et al. Among authors: riley nm. Nat Chem Biol. 2021 Sep;17(9):937-946. doi: 10.1038/s41589-021-00770-1. Epub 2021 Mar 25. Nat Chem Biol. 2021. PMID: 33767387 Free PMC article.

4

Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7.

Wisnovsky S, Möckl L, Malaker SA, Pedram K, Hess GT, Riley NM, Gray MA, Smith BAH, Bassik MC, Moerner WE, Bertozzi CR. Wisnovsky S, et al. Among authors: riley nm. Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):e2015024118. doi: 10.1073/pnas.2015024118. Proc Natl Acad Sci U S A. 2021. PMID: 33495350 Free PMC article.

5

The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type C.

Pluvinage JV, Sun J, Claes C, Flynn RA, Haney MS, Iram T, Meng X, Lindemann R, Riley NM, Danhash E, Chadarevian JP, Tapp E, Gate D, Kondapavulur S, Cobos I, Chetty S, Pașca AM, Pașca SP, Berry-Kravis E, Bertozzi CR, Blurton-Jones M, Wyss-Coray T. Pluvinage JV, et al. Among authors: riley nm. Sci Transl Med. 2021 Dec;13(622):eabg2919. doi: 10.1126/scitranslmed.abg2919. Epub 2021 Dec 1. Sci Transl Med. 2021. PMID: 34851695 Free PMC article.

6

Efficacy and feasibility of HIIT training for university students: The Uni-HIIT RCT.

Eather N, Riley N, Miller A, Smith V, Poole A, Vincze L, Morgan PJ, Lubans DR. Eather N, et al. Among authors: riley n. J Sci Med Sport. 2019 May;22(5):596-601. doi: 10.1016/j.jsams.2018.11.016. Epub 2018 Nov 24. J Sci Med Sport. 2019. PMID: 30509862 Clinical Trial.

7

Perilunate Injuries: Current Aspects of Management.

Kinghorn A, Finlayson G, Faulkner A, Riley N. Kinghorn A, et al. Among authors: riley n. Injury. 2021 Oct;52(10):2760-2767. doi: 10.1016/j.injury.2021.09.012. Injury. 2021. PMID: 34717826 Review.

8

A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry-Based Glycoproteomics.

Riley NM, Bertozzi CR, Pitteri SJ. Riley NM, et al. Mol Cell Proteomics. 2021;20:100029. doi: 10.1074/mcp.R120.002277. Epub 2020 Dec 20. Mol Cell Proteomics. 2021. PMID: 33583771 Free PMC article. Review.

9

Modulation of immune cell reactivity with cis-binding Siglec agonists.

Delaveris CS, Chiu SH, Riley NM, Bertozzi CR. Delaveris CS, et al. Among authors: riley nm. Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):e2012408118. doi: 10.1073/pnas.2012408118. Proc Natl Acad Sci U S A. 2021. PMID: 33431669 Free PMC article.

10

Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19.

Delaveris CS, Wilk AJ, Riley NM, Stark JC, Yang SS, Rogers AJ, Ranganath T, Nadeau KC; Stanford COVID-19 Biobank, Blish CA, Bertozzi CR. Delaveris CS, et al. Among authors: riley nm. ACS Cent Sci. 2021 Apr 28;7(4):650-657. doi: 10.1021/acscentsci.0c01669. Epub 2021 Mar 24. ACS Cent Sci. 2021. PMID: 34056095 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results